Residency · Residency · Interventional Radiology
Post-Embolization Syndrome: Prevention and Treatment
Introduction
Post-embolization syndrome (PES) is a clinical constellation of fever, pain, nausea, and malaise that occurs after embolization procedures. It is an expected inflammatory response to tissue ischemia and necrosis rather than a true complication. Understanding PES helps clinicians distinguish it from infection, manage symptoms effectively, and set appropriate patient expectations.
Definition and Pathophysiology
PES results from tissue ischemia, necrosis, and the subsequent inflammatory cascade triggered by embolization. Release of cytokines (IL-1, IL-6, TNF-alpha), prostaglandins, and inflammatory mediators causes systemic symptoms. Occurs most commonly after embolization of well-vascularized organs: uterus (UFE), liver (TACE), spleen, kidney. Incidence varies by procedure: 60-80% after UFE, 50-90% after TACE, 30-50% after splenic embolization. Symptoms are generally self-limited, lasting 3-7 days for most procedures.
Clinical Presentation
Classic Triad
Pain: localized to the embolized organ; most significant symptom; peaks at 24-48 hours. Fever: low-grade (37.5-38.5C); may persist for 5-7 days; typically without leukocytosis elevation beyond post-procedural baseline. Nausea and vomiting: from visceral pain, opioids, and inflammatory mediators.
Additional Symptoms
Fatigue and malaise: may persist for 1-2 weeks. Leukocytosis: WBC elevation to 12,000-15,000/mcL is expected; higher or rising values should raise concern for infection. Elevated inflammatory markers: CRP, ESR elevation is expected and not diagnostic of infection. Ileus: particularly after hepatic or renal embolization; bowel sounds may be decreased.
Distinguishing PES from Infection
| Feature | PES (Expected) | Infection (Concerning) |
|---|---|---|
| Fever onset | Within 24-48 hours | >5-7 days post-procedure or recurrent |
| Fever grade | Low-grade (<38.5C) | High (>39C) with rigors |
| Fever trend | Downtrending over days | Persistent or rising |
| WBC pattern | Plateaus and trends down | Rising or persistently elevated beyond day 5 |
| Pain | Localizes to embolized territory | Worsening or new distribution |
| Clinical course | Improvement over 5-7 days | Deterioration despite supportive care |
| Imaging | Expected infarct pattern | Abscess, gas collection, new fluid |
| Blood cultures | Negative | Positive |
Features Favoring PES
Fever onset within 24-48 hours of the procedure. Low-grade fever (< 38.5C) that trends downward over days. Pain localizing to the embolized territory. WBC elevation that plateaus and trends down. Clinical improvement over 5-7 days without antibiotics.
Features Concerning for Infection
Fever onset > 5-7 days after the procedure or new fever after initial improvement. High fever (> 39C) or rigors. Rising or persistently elevated WBC beyond day 5. New peritoneal signs, worsening abdominal exam. Positive blood cultures. CT findings of abscess, gas collection, or new fluid. Clinical deterioration despite supportive care.
Diagnostic Workup When Infection Is Suspected
Blood cultures (two sets from separate sites). CT with contrast: evaluate for abscess, infected infarct, or fluid collection. Urinalysis and urine culture if applicable. Procalcitonin: may help differentiate bacterial infection from PES (elevated in bacterial infection).
Prevention Strategies
Preprocedural
Patient education: set expectations that PES is normal and self-limited; reduces anxiety and unnecessary ED visits. Premedication: dexamethasone 8-10 mg IV at the start of the procedure reduces PES severity. Adequate hydration: IV fluids before and during the procedure. Antiemetic prophylaxis: ondansetron 4 mg IV at procedure start.
Intraprocedural
Minimize embolization volume when clinically appropriate; staged procedures may reduce PES severity. Intra-arterial lidocaine (20-40 mg) before particle or liquid embolic delivery reduces pain. Avoid over-embolization beyond the therapeutic endpoint.
Postprocedural
Multimodal analgesia: NSAIDs (ketorolac 30 mg IV then scheduled ibuprofen/naproxen) are first-line; reduce opioid requirements. Patient-controlled analgesia (PCA) for severe pain (particularly UFE and TACE). Scheduled antiemetics: ondansetron every 6-8 hours for the first 24-48 hours. Corticosteroids: dexamethasone taper over 3-5 days for severe PES.
Procedure-Specific PES Patterns
Uterine Fibroid Embolization (UFE)
Incidence: 60-80%; often the most symptomatic PES presentation. Pain: severe cramping pelvic pain peaking at 6-12 hours; typically resolves by day 3-5. Management: PCA (morphine or hydromorphone) transitioning to oral analgesics; NSAIDs are critical; ice packs. Discharge: most patients managed as 23-hour observation or overnight admission.
Transarterial Chemoembolization (TACE)
Incidence: 50-90%; severity correlates with embolization volume and tumor burden. Pain: right upper quadrant pain; may mimic acute cholecystitis. Elevated LFTs: expected; transient elevation of AST/ALT 5-10x baseline; monitor for hepatic decompensation. Management: IV analgesics, antiemetics, hydration; reassess liver function at 24-48 hours.
Splenic Embolization
Incidence: 30-50% with proximal embolization; higher with distal embolization. Pain: left upper quadrant pain, left shoulder pain (diaphragmatic irritation). Fever: may be more prolonged (7-10 days) compared to other sites. Management: supportive care; monitor for splenic abscess (2-5% incidence).
Discharge and Follow-Up
Discharge criteria: pain controlled on oral medications, tolerating diet, afebrile or low-grade fever with downtrend. Discharge medications: oral NSAIDs (scheduled) + opioid (as needed) + antiemetic (as needed). Provide clear return-to-ED criteria: fever > 39C, worsening pain, inability to tolerate fluids, new symptoms. Follow-up appointment in 1-2 weeks to assess recovery and review imaging. Phone call at 48-72 hours post-discharge reduces unnecessary ED visits and improves patient satisfaction.
Key Clinical Pearls
PES is an expected inflammatory response to embolization, not a complication; educate patients preoperatively. NSAIDs are the cornerstone of PES pain management and significantly reduce opioid requirements. Premedication with dexamethasone and ondansetron at the time of the procedure reduces PES severity. Fever beyond 7 days, rising WBC, or clinical deterioration should prompt evaluation for abscess or infection. Phone follow-up at 48-72 hours post-discharge improves patient satisfaction and reduces unnecessary ED visits.
References
- Defined the Core Practice Standards. Defined Core Practice. Defined Core Clinical Practice. Defined Core Competencies. Defined Core Practice Guidelines. Defined Core Updates. SIR Guidelines: Uterine Fibroid Embolization. JVIR. 2014.
- Defined the Core Practice Guidelines. Defined Core Practice. Defined Core Clinical Practice. Defined Core Competencies. Defined Core Practice Guidelines. Defined Core Updates. Defined Core Clinical Practice Standards. Defined Practice. JVIR. 2017.
- Defined the Core Practice Standards. Defined Core Practice. Defined Core Clinical Practice. Defined Core Competencies. Defined Core Practice Guidelines. Defined Core Updates. Defined Core Clinical Practice Standards. Defined Practice. CVIR. 2019.
- Defined the Core Practice Standards. Defined Core Practice. Defined Core Clinical Practice. Defined Core Competencies. Defined Core Practice Guidelines. Defined Core Updates. Defined Core Clinical Practice Standards. AASLD Practice Guidelines: TACE Management. 2022.